ArticleMedicine2025

Predictive power of tertiary lymphoid structure for prognosis and neoadjuvant chemotherapy response in HER2-positive breast cancer.

Mengxi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.